Rockefeller Capital Management »

Aligos Therapeutics shares owned by Rockefeller Capital Management

Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by Rockefeller Capital Management from 13F filings

Historical chart of Rockefeller Capital Management investment in Aligos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aligos Therapeutics held by Rockefeller Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aligos Therapeutics by Rockefeller Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $9.8k 1.0k 9.80

More positions owned by Rockefeller Capital Management

Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
NVIDIA Corporation (NVDA)
salesforce (CRM)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Tidal Trust Iii Rockefeller Glob (RGEF)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Tidal Trust Iii Rockefeller Us S (RSMC)
JPMorgan Chase & Co. (JPM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for Rockefeller Capital Management

Top funds holding Aligos Therapeutics

Woodline Partners
Deep Track Capital
Alyeska Investment Group
Sio Capital Management
Readystate Asset Management
Vanguard Group
Adage Capital Partners GP
Baker Bros. Advisors
Hillhouse Capital Advisors
LPL Financial
Renaissance Technologies
Geode Capital Management
Two Sigma Investments
Squarepoint Ops
UBS Group

View all funds holding Aligos Therapeutics